Free Trial

Co-Diagnostics (CODX) Short Interest Ratio & Short Volume

Co-Diagnostics logo
$1.03 -0.01 (-0.96%)
(As of 10:25 AM ET)

Co-Diagnostics Short Interest Data

Co-Diagnostics (CODX) has a short interest of 208,700 shares. This marks a -7.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 137,079 shares to cover all short positions.

Current Short Interest
208,700 shares
Previous Short Interest
226,400 shares
Change Vs. Previous Month
-7.82%
Dollar Volume Sold Short
$252,527.00
Short Interest Ratio
0.8 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
31,930,000 shares
Percentage of Shares Shorted
0.65%
Today's Trading Volume
8,964 shares
Average Trading Volume
137,079 shares
Today's Volume Vs. Average
7%
Short Selling Co-Diagnostics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Co-Diagnostics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CODX Short Interest Over Time

CODX Days to Cover Over Time

CODX Percentage of Float Shorted Over Time

Co-Diagnostics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024208,700 shares $252,527.00 -7.8%N/A0.8 $1.21
10/15/2024226,400 shares $285,264.00 +10.3%N/A0.9 $1.26
9/30/2024205,300 shares $256,625.00 -9.1%N/A0.8 $1.25
9/15/2024225,800 shares $295,798.00 -30.9%N/A0.9 $1.31
8/31/2024326,900 shares $454,391.00 +8.6%N/A1.2 $1.39
8/15/2024300,900 shares $373,116.00 -2.9%N/A1.2 $1.24
7/31/2024309,900 shares $356,385.00 -12.3%N/A2.4 $1.15
7/15/2024353,200 shares $453,862.00 -20.4%N/A2.9 $1.29
6/30/2024443,600 shares $554,500.00 +25.1%N/A3.7 $1.25
6/15/2024354,700 shares $563,973.00 -2.2%N/A3 $1.59
5/31/2024362,600 shares $380,730.00 +14.9%N/A3.9 $1.05
5/15/2024315,500 shares $353,360.00 -30.6%N/A5.5 $1.12
4/30/2024454,700 shares $527,452.00 +0.4%N/A8 $1.16
4/15/2024453,000 shares $534,540.00 -8.8%N/A8 $1.18
3/31/2024496,500 shares $556,080.00 +30.1%N/A7.5 $1.12
3/15/2024381,500 shares $408,205.00 +11.8%N/A4.2 $1.07
2/29/2024341,300 shares $385,669.00 -28.3%N/A3.7 $1.13
2/15/2024475,700 shares $551,812.00 +32.3%N/A4.7 $1.16
1/31/2024359,600 shares $449,500.00 -36.9%N/A3.3 $1.25
1/15/2024570,000 shares $798,000.00 -9.8%N/A5.2 $1.40
12/31/2023632,000 shares $840,560.00 +27.3%N/A6.2 $1.33
12/15/2023496,400 shares $565,896.00 -25.0%N/A6 $1.14
11/30/2023661,900 shares $781,042.00 -0.7%N/A8.9 $1.18
11/15/2023666,600 shares $926,574.00 +36.2%N/A8.5 $1.39
10/31/2023489,400 shares $523,658.00 -30.1%N/A7.2 $1.07
10/15/2023699,600 shares $741,576.00 -1.0%N/A8.3 $1.06
9/30/2023706,600 shares $748,996.00 +21.5%N/A5.7 $1.06
9/15/2023581,400 shares $680,238.00 -27.4%N/A4.6 $1.17
8/31/2023800,500 shares $992,620.00 -0.1%N/A6.4 $1.24
8/15/2023801,100 shares $969,331.00 +7.1%N/A6.4 $1.21
7/31/2023748,300 shares $1.17 million -2.4%N/A5.9 $1.56
7/15/2023766,900 shares $1.04 million +13.6%N/A6.6 $1.35
6/30/2023675,200 shares $749,472.00 -3.8%N/A7.2 $1.11
6/15/2023701,800 shares $757,944.00 +17.2%N/A5.9 $1.08
5/31/2023598,800 shares $652,692.00 -17.2%N/A4.2 $1.09
5/15/2023723,400 shares $976,590.00 -13.0%N/A5.3 $1.35
4/30/2023831,400 shares $1.15 million -3.1%N/A6.4 $1.38
4/15/2023857,900 shares $1.34 million -19.8%N/A6 $1.56
3/31/20231,070,000 shares $1.58 million +2.9%N/A7.5 $1.48
3/15/20231,040,000 shares $3.03 million -20.6%N/A7.7 $2.91
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

2/28/20231,310,000 shares $3.79 million +12.9%N/A10.9 $2.89
2/15/20231,160,000 shares $3.35 million -25.6%N/A8.7 $2.89
1/31/20231,560,000 shares $5.05 million +21.9%N/A10.9 $3.24
1/15/20231,280,000 shares $3.80 million -3.8%N/A8.8 $2.97
12/30/20221,330,000 shares $3.35 million -7.0%N/A8.5 $2.52
12/15/20221,430,000 shares $3.58 million -21.0%N/A8.4 $2.50
11/30/20221,810,000 shares $5.45 million -25.5%N/A9.3 $3.01
11/15/20222,430,000 shares $8.94 million +3.4%N/A9.2 $3.68
10/31/20222,350,000 shares $8.15 million +15.8%N/A5.5 $3.47
10/15/20222,030,000 shares $6.31 million +8.6%N/A3.7 $3.11
9/30/20221,870,000 shares $6.00 million -19.7%N/A3 $3.21
9/15/20222,330,000 shares $7.55 million +1.8%N/A3.5 $3.24
8/31/20222,290,000 shares $7.74 million +9.1%N/A3.5 $3.38
8/15/20222,100,000 shares $9.05 million +1.5%N/A3.1 $4.31
7/31/20222,070,000 shares $13.58 million +20.4%N/A3.9 $6.56
7/15/20221,720,000 shares $9.94 million -9.5%N/A4 $5.78
6/30/20221,900,000 shares $10.66 million +2.7%N/A5.1 $5.61
6/15/20221,850,000 shares $9.92 million No ChangeN/A5.1 $5.36
5/31/20221,850,000 shares $9.34 million -17.8%N/A4.6 $5.05
5/15/20222,250,000 shares $10.24 million +57.3%N/A6.3 $4.55
4/30/20221,430,000 shares $6.29 million -29.9%N/A4 $4.40
4/15/20222,040,000 shares $11.49 million +7.4%N/A5.1 $5.63
3/31/20221,900,000 shares $11.74 million +24.2%N/A4.2 $6.18
3/15/20221,530,000 shares $8.71 million +0.7%N/A2.4 $5.69
2/28/20221,520,000 shares $8.82 million -22.5%N/A2.5 $5.80
2/15/20221,960,000 shares $13.48 million +4.8%N/A3 $6.88
1/31/20221,870,000 shares $13.28 million +16.2%N/A2.7 $7.10
1/15/20221,610,000 shares $14.26 million +12.6%N/A2.3 $8.86
12/31/20211,430,000 shares $12.77 million +13.5%N/A2.2 $8.93
12/15/20211,260,000 shares $10.48 million -9.4%N/A2.2 $8.32
11/30/20211,390,000 shares $13.40 million -37.1%N/A2.9 $9.64
11/15/20212,210,000 shares $21.39 million +33.1%N/A4.6 $9.68
10/29/20211,660,000 shares $13.63 million -20.6%N/A2.4 $8.21
10/15/20212,090,000 shares $17.51 million -2.8%N/A2.5 $8.38
9/30/20212,150,000 shares $20.92 million -3.2%N/A1.8 $9.73
9/15/20212,220,000 shares $21.47 million -7.1%N/A1.8 $9.67
8/31/20212,390,000 shares $25.69 million -23.4%N/A1.9 $10.75
8/13/20213,120,000 shares $33.07 million +3.3%N/A2.4 $10.60
7/30/20213,020,000 shares $30.53 million -9.9%N/A2.6 $10.11
7/15/20213,350,000 shares $25.53 million -7.5%N/A3.2 $7.62
6/30/20213,620,000 shares $29.87 million -22.7%N/A4.6 $8.25
6/15/20214,680,000 shares $40.48 million -3.5%17.3%5 $8.65
5/28/20214,850,000 shares $39.14 million -0.4%18.0%5.1 $8.07
5/14/20214,870,000 shares $34.87 million +7.7%N/A4.6 $7.16
4/30/20214,520,000 shares $40.14 million +6.4%N/A3.6 $8.88
4/15/20214,250,000 shares $39.95 million -14.1%N/A3 $9.40
3/31/20214,950,000 shares $42.27 million +21.0%N/A3.2 $8.54
3/15/20214,090,000 shares $57.01 million +3.5%N/A2.7 $13.94
2/26/20213,950,000 shares $60.83 million -20.8%N/A2.5 $15.40
2/12/20214,990,000 shares $80.84 million -1.2%N/A2.7 $16.20
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

1/29/20215,050,000 shares $63.83 million -15.6%N/A2.5 $12.64
1/15/20215,980,000 shares $60.76 million -8.4%N/A3 $10.16
12/31/20206,530,000 shares $63.54 million -4.1%N/A3.5 $9.73
12/15/20206,810,000 shares $72.59 million -6.5%N/A3.5 $10.66
11/30/20207,280,000 shares $86.56 million +4.8%N/A2.7 $11.89
11/15/20206,950,000 shares $104.11 million +7.6%N/A2.3 $14.98
10/30/20206,460,000 shares $89.21 million -4.0%N/A2 $13.81
10/15/20206,730,000 shares $95.97 million -2.8%N/A1.9 $14.26
9/30/20206,920,000 shares $94.04 million -17.6%N/A1.8 $13.59
9/15/20208,400,000 shares $104.92 million +7.0%N/A2 $12.49
8/31/20207,850,000 shares $85.57 million +18.1%N/A2 $10.90
8/14/20206,650,000 shares $108.33 million +6.9%N/A2 $16.29
7/31/20206,220,000 shares $149.28 million +3.7%N/A1.3 $24.00
7/15/20206,000,000 shares $108.66 million +23.5%N/A1.1 $18.11
6/30/20204,860,000 shares $94.04 million +48.2%N/A0.8 $19.35
6/15/20203,280,000 shares $57.14 million -7.9%N/A0.5 $17.42
5/29/20203,560,000 shares $64.08 million -35.9%N/A0.4 $18.00
5/15/20205,550,000 shares $94.74 million +11.5%N/A0.4 $17.07
4/30/20204,980,000 shares $56.47 million +5.3%N/A0.4 $11.34
4/15/20204,730,000 shares $44.94 million -0.2%N/A0.3 $9.50
3/31/20204,740,000 shares $68.26 million +29.7%N/A0.4 $14.40
3/13/20203,655,500 shares $32.17 million +48.6%N/A0.2 $8.80
2/28/20202,460,000 shares $23.27 million +12.8%N/A0.3 $9.46
2/14/20202,180,000 shares $15.02 million +26.7%12.9%0.4 $6.89
1/31/20201,720,000 shares $15.31 million +186.1%13.4%0.5 $8.90
1/15/2020601,200 shares $1.96 million +0.7%5.6%0.5 $3.26
12/31/2019596,900 shares $1.12 million -0.6%5.6%5.3 $1.88

CODX Short Interest - Frequently Asked Questions

What is Co-Diagnostics' current short interest?

Short interest is the volume of Co-Diagnostics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 208,700 shares of CODX short. Learn More on Co-Diagnostics' current short interest.

What is a good short interest ratio for Co-Diagnostics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CODX shares currently have a short interest ratio of 1.0. Learn More on Co-Diagnostics's short interest ratio.

Is Co-Diagnostics' short interest increasing or decreasing?

Co-Diagnostics saw a decline in short interest in October. As of October 31st, there was short interest totaling 208,700 shares, a decline of 7.8% from the previous total of 226,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Co-Diagnostics' short interest compare to its competitors?

Here is how the short interest of companies compare to Co-Diagnostics: TriSalus Life Sciences, Inc. (1.26%), TELA Bio, Inc. (1.22%), Fractyl Health, Inc. (9.61%), FONAR Co. (0.15%), Edap Tms S.A. (0.18%), LENSAR, Inc. (0.55%), Vivani Medical, Inc. (2.50%), Modular Medical, Inc. (2.23%), Monogram Orthopaedics, Inc. (1.36%), electroCore, Inc. (0.83%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Co-Diagnostics stock?

Short selling CODX is an investing strategy that aims to generate trading profit from Co-Diagnostics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Co-Diagnostics?

A short squeeze for Co-Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CODX, which in turn drives the price of the stock up even further.

How often is Co-Diagnostics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CODX, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:CODX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners